Keybank National Association OH Acquires 230,529 Shares of Henry Schein, Inc. (HSIC)
Keybank National Association OH increased its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 97.9% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 465,948 shares of the company’s stock after acquiring an additional 230,529 shares during the period. Keybank National Association OH owned about 0.29% of Henry Schein worth $38,203,000 at the end of the most recent reporting period.
Several other institutional investors have also modified their holdings of HSIC. Alecta Pensionsforsakring Omsesidigt boosted its position in shares of Henry Schein by 112.0% during the 3rd quarter. Alecta Pensionsforsakring Omsesidigt now owns 5,313,980 shares of the company’s stock valued at $435,693,000 after acquiring an additional 2,806,990 shares in the last quarter. Janus Henderson Group PLC lifted its holdings in Henry Schein by 394.1% during the 2nd quarter. Janus Henderson Group PLC now owns 1,465,303 shares of the company’s stock valued at $268,173,000 after purchasing an additional 1,168,763 shares during the last quarter. Swedbank lifted its holdings in Henry Schein by 84.9% during the 3rd quarter. Swedbank now owns 2,358,594 shares of the company’s stock valued at $193,381,000 after purchasing an additional 1,083,115 shares during the last quarter. Fisher Asset Management LLC lifted its holdings in Henry Schein by 99.3% during the 3rd quarter. Fisher Asset Management LLC now owns 844,106 shares of the company’s stock valued at $69,208,000 after purchasing an additional 420,637 shares during the last quarter. Finally, Riverbridge Partners LLC lifted its holdings in Henry Schein by 235.8% during the 3rd quarter. Riverbridge Partners LLC now owns 458,340 shares of the company’s stock valued at $37,579,000 after purchasing an additional 321,851 shares during the last quarter. Institutional investors and hedge funds own 48.16% of the company’s stock.
In related news, SVP Paul Rose sold 2,126 shares of the business’s stock in a transaction that occurred on Wednesday, September 6th. The shares were sold at an average price of $172.51, for a total transaction of $366,756.26. Following the completion of the sale, the senior vice president now directly owns 17,841 shares of the company’s stock, valued at $3,077,750.91. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Insiders own 1.19% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: This piece of content was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece of content on another publication, it was stolen and reposted in violation of US and international trademark and copyright legislation. The correct version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/11/07/keybank-national-association-oh-acquires-230529-shares-of-henry-schein-inc-hsic.html.
Henry Schein, Inc. (NASDAQ:HSIC) traded down $7.60 on Tuesday, hitting $70.04. 7,690,869 shares of the company were exchanged, compared to its average volume of 1,650,000. The company has a debt-to-equity ratio of 0.28, a quick ratio of 0.85 and a current ratio of 1.55. The company has a market capitalization of $11,220.00, a P/E ratio of 21.96, a price-to-earnings-growth ratio of 2.08 and a beta of 1.03. Henry Schein, Inc. has a twelve month low of $69.51 and a twelve month high of $93.50.
Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Monday, November 6th. The company reported $0.87 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.90 by ($0.03). The business had revenue of $3.16 billion for the quarter, compared to the consensus estimate of $3.05 billion. Henry Schein had a return on equity of 19.91% and a net margin of 4.59%. The company’s quarterly revenue was up 10.3% on a year-over-year basis. During the same period last year, the firm earned $0.84 earnings per share. equities analysts anticipate that Henry Schein, Inc. will post 3.64 earnings per share for the current fiscal year.
Henry Schein announced that its board has authorized a share buyback program on Monday, September 18th that allows the company to buyback $400.00 million in shares. This buyback authorization allows the company to purchase up to 6.3% of its shares through open market purchases. Shares buyback programs are usually an indication that the company’s board of directors believes its stock is undervalued.
Several equities analysts recently issued reports on the stock. Jefferies Group LLC reissued a “hold” rating and set a $88.50 price target on shares of Henry Schein in a report on Friday, July 21st. Piper Jaffray Companies raised shares of Henry Schein from a “neutral” rating to an “overweight” rating in a report on Friday, September 15th. Royal Bank Of Canada cut their price target on shares of Henry Schein from $91.00 to $82.00 and set a “sector perform” rating for the company in a report on Tuesday. Craig Hallum raised shares of Henry Schein from a “hold” rating to a “buy” rating in a report on Tuesday. Finally, Stifel Nicolaus cut their price target on shares of Henry Schein from $89.00 to $77.00 and set a “hold” rating for the company in a report on Tuesday. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and seven have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average price target of $89.88.
About Henry Schein
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).
Receive News & Stock Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related stocks with our FREE daily email newsletter.